Iannone Robert 4

What Happened
Robert Iannone, EVP, Global Head of R&D & CMO at Jazz Pharmaceuticals, had 3,764 shares withheld to satisfy tax obligations arising from the vesting of restricted stock units. The filing shows the shares were disposed under transaction code F at $237.72 per share, for an aggregate value of $894,778. This is a tax-withholding/cashless disposition of vested RSUs, not an open-market sale.

Key Details

• Transaction date: 2026-06-30
• Filing date: 2026-07-02
• Shares withheld/disposed: 3,764 shares at $237.72 each; total ~$894,778
• Transaction code: F — payment of exercise price or tax liability (shares withheld)
• Footnote: F1 — shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units (RSUs)
• Shares owned after transaction: not specified in the filing
• Timeliness: filing date provided; the report does not indicate a late filing flag

Context
Tax-withholding on vested RSUs is routine and reflects tax obligations, not a discretionary open-market sale. These transactions reduce the net shares the insider receives but generally should not be read as a directional signal about the insider’s view of the company. Purchases or open-market sales are typically more informative about insider sentiment.